Good News to Cancer Patients — Metabolic Research and Cornerstone Pharmaceuticals Conduct a New Animal Study
August 27th, 2007
Metabolic Research, Inc. announced today that an animal study conducted in cooperation with Cornerstone Pharmaceuticals, Inc. of Cranbury, NJ, confirmed that “ABL-SA” protein found in a Brazilian mushroom (a key component in Metabolic Research’s Polimmune â„¢ supplement) is effective in avidly binding to particularly aggressive lung cancer cells called H460, in mice.